TaiMed Biologics Working Capital to Net Assets Ratio
TaiMed Biologics working capital to net assets ratio. TaiMed Biologics (4147) has a Working Capital to Net Assets ratio of 77.8% as of June 2026. Working capital of NT$2.86 Billion (current assets of NT$3.06 Billion minus current liabilities of NT$197.62 Million) is measured against net assets of NT$3.68 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of TaiMed Biologics (2015–2025)
Working capital to net assets ratio of TaiMed Biologics from 2015 to 2025. This chart shows how TaiMed Biologics's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of June 2026, the ratio stands at 77.8%, reflecting working capital of NT$2.86 Billion against net assets of NT$3.68 Billion TWD. Explore 4147 long-term investments to assets to see how much of total assets are deployed in long-term investments.
TaiMed Biologics Working Capital to Net Assets Ratio by Year (2015–2025)
TaiMed Biologics working capital to net assets ratio by year from 2015 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for TaiMed Biologics from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see TaiMed Biologics asset portfolio.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 79.6% | NT$3.07 Billion | NT$3.86 Billion | NT$3.32 Billion | NT$253.51 Million | ▼ -1.5 pp |
| 2024 | 81.0% | NT$3.26 Billion | NT$4.02 Billion | NT$3.39 Billion | NT$134.76 Million | ▲ +11.2 pp |
| 2023 | 69.8% | NT$1.79 Billion | NT$2.57 Billion | NT$2.15 Billion | NT$361.17 Million | ▲ +2.2 pp |
| 2022 | 67.6% | NT$1.84 Billion | NT$2.71 Billion | NT$2.16 Billion | NT$329.86 Million | ▼ -4.1 pp |
| 2021 | 71.7% | NT$2.11 Billion | NT$2.94 Billion | NT$2.33 Billion | NT$225.08 Million | ▲ +3.9 pp |
| 2020 | 67.8% | NT$2.32 Billion | NT$3.42 Billion | NT$2.78 Billion | NT$461.52 Million | ▲ +11.2 pp |
| 2019 | 56.6% | NT$2.03 Billion | NT$3.59 Billion | NT$2.46 Billion | NT$428.11 Million | ▲ +0.6 pp |
| 2018 | 55.9% | NT$2.28 Billion | NT$4.08 Billion | NT$2.52 Billion | NT$235.94 Million | ▼ -27.0 pp |
| 2017 | 82.9% | NT$3.56 Billion | NT$4.29 Billion | NT$3.66 Billion | NT$98.59 Million | ▼ -9.8 pp |
| 2016 | 92.8% | NT$4.37 Billion | NT$4.71 Billion | NT$4.43 Billion | NT$60.17 Million | ▼ -0.1 pp |
| 2015 | 92.8% | NT$4.55 Billion | NT$4.90 Billion | NT$4.58 Billion | NT$26.63 Million | — |